CD163 (Gene)

Organism:

Homo sapiens

Synonyms:CD163 molecule, CD163, ENTREZ:9332, HGNC:1631, M130, MIM:605545, MM130, NM_001370145, NM_001370146, NM_004244, NM_203416, NP_001357074, NP_001357075, NP_004235, NP_981961, NR_163255, SCARI1, XM_024449278, XP_024305046, XR_002957389

Omim:OMIM:605545

Id:22e60ed7-dcd9-57c1-8e6a-304d31533663

Hgnc:HGNC:1631

Entrez:9332

Ensembl:ENSG00000177575

Description:CD163 molecule

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CD163's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CD163.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CD163.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CD163.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CD163.

Results found

Linked to

	Label	Description
	T61-Colon Consensus Gene Set (Entity type)	A Gene Set from MoTrPAC
	GSE261563 CX-5461 7 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204 GSE211619 glutamine 4 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE167173 PD-L1 knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203579 GSE203581 adenosine 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE245677 CDK2 inhibition 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204 GSE211619 glutamine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265849 MrgD overexpression muscle organ 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE262808 histone H3 inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

T61-Colon Consensus

Gene Set (Entity type)

A Gene Set from MoTrPAC

GSE261563 CX-5461 7 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199204 GSE211619 glutamine 4 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 0 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE167173 PD-L1 knockdown 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE203579 GSE203581 adenosine 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE245677 CDK2 inhibition 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE199204 GSE211619 glutamine 4 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE265849 MrgD overexpression muscle organ 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE262808 histone H3 inhibition 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.